Safety of veralipride for the treatment of vasomotor symptoms of menopause-Reference-Cited by-同舟云学术

Safety of veralipride for the treatment of vasomotor symptoms of menopause

Published:2014-05 Issue:5 Volume:21 Page:484-492
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:

Author:

Hernández Valencia Marcelino,Vega Arias María de Jesús,Celis González Cuauhtémoc,Hernández Marín Imelda,Martín González Juan Humberto,Morcate Campos Enrique Rafael,Basavilvazo Rodríguez María Antonia,Morales Álvarez Ignacio,Valdés Vargas María Antonia,Otero Flores José Braulio Everardo,Santoyo Haro Samuel,Cortes Bonilla Manuel,Bernardo Escudero Roberto,Alonso Campero Rosalba

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference13 articles.

1. Le veralipride dans le traitement des bouffees de chaleur de la menopause.;Passetto;Rev Fr Gynecol Obstet,1985

2. Modification of vasomotor symptoms after various treatment modalities in the postmenopause.;Carranza;Int J Gynecol Obstet,2001

3. The safety of veralipride.;De Leo;Expert Opin Drug Saf,2006

4. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes.;Zichella;Maturitas,1986

5. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.;Verbeke;Maturitas,1988

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sulpiride on menopausal hot flashes: a randomized, double-blind, placebo-controlled clinical trial;Gynecological Endocrinology;2019-09-03

2. EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms;Maturitas;2015-07